CNBC's Bertha Coombs reports on high-flying health tech firms' stock performance.

Better Growth Stock: Teladoc vs. Hims & Hers

09:07am, Sunday, 13'th Nov 2022
A showdown between two hot telehealth companies.

Hims & Hers Health: Gobble Up Shares While You Can

03:41pm, Wednesday, 09'th Nov 2022
Hims posted another excellent quarter with record-breaking subscriptions and revenue. AOV, Retention Rates, and Churn Rates are all at impressive levels. Management delivered on its promises to scale

Why Hims & Hers Health Stock Soared Today

04:44pm, Tuesday, 08'th Nov 2022
Profitability could come sooner than investors expected.
Hims & Hers CFO Yemi Okupe joins Yahoo Finance Live to discuss business and subscription growth, reaching more consumers, removing the stigma around sexual health and reproductive conditions, and weat

Why Is Hims & Hers (HIMS) Stock Up 24% Today?

10:57am, Tuesday, 08'th Nov 2022
Hims & Hers (NYSE: HIMS ) stock is climbing higher on Tuesday after reporting results for the third quarter of 2022. Investors are especially taking note of the company's newest guidance in that earni
Hims & Hers Health, Inc. (NYSE:HIMS ) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Christine Greany - The Blueshirt Group Andrew Dudum - Chief Executive Officer Ye
After losing some value lately, a hammer chart pattern has been formed for Hims & Hers Health, Inc. (HIMS), indicating that the stock has found support. This, combined with an upward trend in earnings

This Stock Could 10X in 5 Years

09:37am, Wednesday, 02'nd Nov 2022
An assessment of the company's prospects reveal an ecouraging outlook.

Hims & Hers Looks Extremely Cheap, I Am Buying

02:37pm, Tuesday, 25'th Oct 2022
HIMS shares plunged more than 80% from their all-time high. The company is growing at a very fast pace and has a very strong balance sheet.
Hims & Hers Health, Inc. (HIMS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analy

Hims & Hers: The Market Has Lost Its Mind

10:02am, Friday, 21'st Oct 2022
Hims & Hers has been beset by unrelenting selling pressure since it reached all-time highs last year. This has come against financial results that continue to outperform consensus estimates.
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences t

Hims & Hers: Just What The Doctor Ordered

10:01am, Friday, 16'th Sep 2022
Hims & Hers has now reported back-to-back quarters with over 100K net new subscriptions. The telehealth platform expects to approach a $540 million annual sales run rate in Q4.
Amazon will shut down its healthcare service business. Telehealth stocks are rising Thursday.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE